A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

OBJECTIVE: Serum CA-125 values have been advocated in the monitoring of ovarian cancer patients receiving intravenous (IV) chemotherapy. This evaluation sought to determine if the CA-125 test can be used to monitor treatment effect among patients receiving intraperitoneal chemotherapy (IP). METHODS:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gynecol Oncol
Main Authors: Krivak, Thomas C., Tian, Chunqiao, Rose, G. Scott, Armstrong, Deborah K., Maxwell, G. Larry
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380179/
https://ncbi.nlm.nih.gov/pubmed/19596139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.06.021
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares